Follows pregnant women with cystic fibrosis and their babies after treatment
Observes women with cystic fibrosis taking elexacaftor-tezacaftor-ivacaftor during pregnancy and breastfeeding.
Plain-language title generated from the registry record
Registry title: CFTR Modulators in Pregnancy and Postpartum
Key facts
- Where
- Stockholm, SwedenSee the site
Where in Sweden
- Stockholm CF centerStockholm, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Region Stockholm
- Trial code
- NCT06302270
- Record updated
- 8 March 2024
- Original description
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.Read full original descriptionShow less
Monitoring of Women and Children Exposed to the Combination of Elexacaftor-tezacaftor-ivacaftor During Bregnancy and Through Mother's Own Milk.
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
Inclusion: Woman with cystic fibrosis who is pregnant and treated with Kaftrio. Newborn infant to the above mentioned woman.
Exclusion: none.